Paving a New Era in Patient Centric Care through Innovations in Precision Medicine

Author(s):  
Mark D. Fidock ◽  
Glen Hughes ◽  
Alain J. van Gool ◽  
Claudio Carini
2021 ◽  
Vol 23 (7) ◽  
Author(s):  
Sally Yu Shi ◽  
Xin Luo ◽  
Tracy M. Yamawaki ◽  
Chi-Ming Li ◽  
Brandon Ason ◽  
...  

Abstract Purpose of Review Cardiac fibroblast activation contributes to fibrosis, maladaptive remodeling and heart failure progression. This review summarizes the latest findings on cardiac fibroblast activation dynamics derived from single-cell transcriptomic analyses and discusses how this information may aid the development of new multispecific medicines. Recent Findings Advances in single-cell gene expression technologies have led to the discovery of distinct fibroblast subsets, some of which are more prevalent in diseased tissue and exhibit temporal changes in response to injury. In parallel to the rapid development of single-cell platforms, the advent of multispecific therapeutics is beginning to transform the biopharmaceutical landscape, paving the way for the selective targeting of diseased fibroblast subpopulations. Summary Insights gained from single-cell technologies reveal critical cardiac fibroblast subsets that play a pathogenic role in the progression of heart failure. Combined with the development of multispecific therapeutic agents that have enabled access to previously “undruggable” targets, we are entering a new era of precision medicine.


2018 ◽  
Vol 22 (6) ◽  
pp. 637-639
Author(s):  
Lisa M. Giles ◽  
David L. Cooper
Keyword(s):  

2020 ◽  
Vol 16 (10) ◽  
pp. 590-599 ◽  
Author(s):  
Costantino Pitzalis ◽  
Ernest H. S. Choy ◽  
Maya H. Buch

Author(s):  
Matteo Cesaroni ◽  
Jessica Schreiter ◽  
Loqmane Seridi ◽  
Jarrat Jordan ◽  
Marc Chevrier ◽  
...  

2019 ◽  
Vol 9 ◽  
Author(s):  
Adil Malik ◽  
Srilakshmi Srinivasan ◽  
Jyotsna Batra

Author(s):  
Tatiana Silva Bevilacqua ◽  
Raphael Mendoza da Nobrega ◽  
Helen Chen ◽  
Plinio Pelegrini Morita

Precision medicine is driving medicine towards a new era where technology and large amounts of data come together to play an essential role in treatment. Data needed to empower and inform decision-makers can be overwhelming to interpret and poses unique challenges related to the visualization of data generated by machine learning and deep learning algorithms. Therefore, the present study aims to provide an in-depth understanding of the challenges, current trends, and opportunities concerning data visualization for precision medicine.


2021 ◽  
Vol 11 (10) ◽  
pp. 1019
Author(s):  
Vianney Gilard ◽  
Stéphane Derrey ◽  
Stéphane Marret ◽  
Soumeya Bekri ◽  
Abdellah Tebani

Since the inception of their profession, neurosurgeons have defined themselves as physicians with a surgical practice. Throughout time, neurosurgery has always taken advantage of technological advances to provide better and safer care for patients. In the ongoing precision medicine surge that drives patient-centric healthcare, neurosurgery strives to effectively embrace the era of data-driven medicine. Neuro-oncology best illustrates this convergence between surgery and precision medicine with the advent of molecular profiling, imaging and data analytics. This convenient convergence paves the way for new preventive, diagnostic, prognostic and targeted therapeutic perspectives. The prominent advances in healthcare and big data forcefully challenge the medical community to deeply rethink current and future medical practice. This work provides a historical perspective on neurosurgery. It also discusses the impact of the conceptual shift of precision medicine on neurosurgery through the lens of neuro-oncology.


Author(s):  
Bram Verstockt ◽  
Nurulamin M Noor ◽  
Urko M Marigorta ◽  
Polychronis Pavlidis ◽  
Parakkal Deepak ◽  
...  

Abstract Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme phenotypes, Crohn’s disease [CD] and ulcerative colitis [UC], which both represent numerous phenotypical variations. Hence, we should no longer approach all IBD patients similarly, but rather aim to rethink clinical classifications and modify treatment algorithms to usher in a new era of precision medicine in IBD. This scientific ECCO workshop aims to provide a state-of-the-art overview on prognostic and predictive markers, shed light on key questions in biomarker development, propose best practices in IBD biomarker development [including trial design], and discuss the potential for multi-omic data integration to help drive further advances to make precision medicine a reality in IBD.


Author(s):  
Maria Teresa Di Martino ◽  
Stefania Meschini ◽  
Katia Scotlandi ◽  
Chiara Riganti ◽  
Enrico De Smaele ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document